These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 20828605)

  • 41. The cytochrome P450-catalyzed metabolism of levomepromazine: a phenothiazine neuroleptic with a wide spectrum of clinical application.
    Wójcikowski J; Basińska A; Daniel WA
    Biochem Pharmacol; 2014 Jul; 90(2):188-95. PubMed ID: 24841887
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An inhibitory monoclonal antibody to human cytochrome P450 2A6 defines its role in the metabolism of coumarin, 7-ethoxycoumarin and 4-nitroanisole in human liver.
    Sai Y; Yang TJ; Krausz KW; Gonzalez FJ; Gelboin HV
    Pharmacogenetics; 1999 Apr; 9(2):229-37. PubMed ID: 10376770
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro assessment of cytochrome P450 inhibition and induction potential of felotaxel (SHR110008).
    Ding Y; Jia Y; Lu C; Liu W; Yang J; Song Y; Zhu Y; Yang L; Ding L; Wen A
    Biomed Pharmacother; 2012 Jun; 66(4):318-21. PubMed ID: 22397757
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quantification of human hepatocyte cytochrome P450 enzymes and transporters induced by HIV protease inhibitors using newly validated LC-MS/MS cocktail assays and RT-PCR.
    Liu L; Mugundu GM; Kirby BJ; Samineni D; Desai PB; Unadkat JD
    Biopharm Drug Dispos; 2012 May; 33(4):207-17. PubMed ID: 22498895
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro assessment of metabolic drug-drug interaction potential of apixaban through cytochrome P450 phenotyping, inhibition, and induction studies.
    Wang L; Zhang D; Raghavan N; Yao M; Ma L; Frost CE; Maxwell BD; Chen SY; He K; Goosen TC; Humphreys WG; Grossman SJ
    Drug Metab Dispos; 2010 Mar; 38(3):448-58. PubMed ID: 19940026
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of cytochrome P450 by ethambutol in human liver microsomes.
    Lee SY; Jang H; Lee JY; Kwon KI; Oh SJ; Kim SK
    Toxicol Lett; 2014 Aug; 229(1):33-40. PubMed ID: 24910189
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ellipticine oxidation and DNA adduct formation in human hepatocytes is catalyzed by human cytochromes P450 and enhanced by cytochrome b5.
    Stiborová M; Poljaková J; Martínková E; Ulrichová J; Simánek V; Dvořák Z; Frei E
    Toxicology; 2012 Dec; 302(2-3):233-41. PubMed ID: 22917556
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of in vitro inhibition and induction of cytochrome P450 activities by hydrolyzed ginkgolides.
    Zhou XW; Ma Z; Geng T; Wang ZZ; Ding G; Yu-an B; Xiao W
    J Ethnopharmacol; 2014 Dec; 158 Pt A():132-9. PubMed ID: 25456428
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro inhibition of human liver cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT) enzymes by rose bengal: system-dependent effects on inhibitory potential.
    Kazmi F; Haupt LJ; Horkman JR; Smith BD; Buckley DB; Wachter EA; Singer JM
    Xenobiotica; 2014 Jul; 44(7):606-14. PubMed ID: 24405273
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Silybin is metabolized by cytochrome P450 2C8 in vitro.
    Jancová P; Anzenbacherová E; Papousková B; Lemr K; Luzná P; Veinlichová A; Anzenbacher P; Simánek V
    Drug Metab Dispos; 2007 Nov; 35(11):2035-9. PubMed ID: 17670841
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation.
    Zanger UM; Schwab M
    Pharmacol Ther; 2013 Apr; 138(1):103-41. PubMed ID: 23333322
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibitory and inductive effects of Phikud Navakot extract on human cytochrome P450.
    Chiangsom A; Lawanprasert S; Oda S; Kulthong K; Luechapudiporn R; Yokoi T; Maniratanachote R
    Drug Metab Pharmacokinet; 2016 Jun; 31(3):210-7. PubMed ID: 27212065
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of potential herb-drug interactions based on the effect of Suxiao Jiuxin Pill on CYP450 enzymes and transporters.
    Qiang T; Li Y; Wang K; Lin W; Niu Z; Wang D; Wang X
    J Ethnopharmacol; 2021 Nov; 280():114408. PubMed ID: 34252529
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro inhibition and induction of human liver cytochrome p450 enzymes by milnacipran.
    Paris BL; Ogilvie BW; Scheinkoenig JA; Ndikum-Moffor F; Gibson R; Parkinson A
    Drug Metab Dispos; 2009 Oct; 37(10):2045-54. PubMed ID: 19608694
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites.
    Marill J; Cresteil T; Lanotte M; Chabot GG
    Mol Pharmacol; 2000 Dec; 58(6):1341-8. PubMed ID: 11093772
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 4-Biphenylaldehyde and 9-anthraldehyde: two fluorescent substrates for determining P450 enzyme activities in rat and human.
    Marini S; Grasso E; Longo V; Puccini P; Riccardi B; Gervasi PG
    Xenobiotica; 2003 Jan; 33(1):1-11. PubMed ID: 12519690
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In-vitro cytotoxicity of ET-743 (Trabectedin, Yondelis), a marine anti-cancer drug, in the Hep G2 cell line: influence of cytochrome P450 and phase II inhibition, and cytochrome P450 induction.
    Brandon EF; Meijerman I; Klijn JS; den Arend D; Sparidans RW; Lázaro LL; Beijnen JH; Schellens JH
    Anticancer Drugs; 2005 Oct; 16(9):935-43. PubMed ID: 16162970
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The in-vitro effect of complementary and alternative medicines on cytochrome P450 2C9 activity.
    Mooiman KD; Goey AK; Huijbregts TJ; Maas-Bakker RF; Beijnen JH; Schellens JH; Meijerman I
    J Pharm Pharmacol; 2014 Sep; 66(9):1339-46. PubMed ID: 24730468
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolism-mediated drug interaction potential of HS-23, a new herbal drug for the treatment of sepsis in human hepatocytes and liver microsomes.
    Jeong HU; Lee JY; Kwon SS; Kim JH; Kim YM; Hong SW; Yeon SH; Lee SM; Cho YY; Lee HS
    Arch Pharm Res; 2015 Feb; 38(2):171-7. PubMed ID: 25052959
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enzyme Kinetics and Molecular Docking Studies on Cytochrome 2B6, 2C19, 2E1, and 3A4 Activities by Sauchinone.
    Gong EC; Chea S; Balupuri A; Kang NS; Chin YW; Choi YH
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29498658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.